Skip to main content
Erschienen in: Archives of Gynecology and Obstetrics 5/2013

01.11.2013 | General Gynecology

The effect of oral evening primrose oil on menopausal hot flashes: a randomized clinical trial

verfasst von: Farah Farzaneh, Setareh Fatehi, Mohammad-Reza Sohrabi, Kamyab Alizadeh

Erschienen in: Archives of Gynecology and Obstetrics | Ausgabe 5/2013

Einloggen, um Zugang zu erhalten

Abstract

Purpose

Hot flashes are common experience for menopausal women, and for many, are severe enough to significantly compromise their overall sense of well being and quality of life. The aim of this study was to compare the efficacy of evening primrose with placebo in improvement of menopausal hot flashes.

Methods

In a 6-week randomized clinical trial, a total of 56 menopausal women aged 45–59 years were participated in this study. The patients were asked for their hot flashes characteristics and responded to HFRDIS (hot flash related daily interference scale) questionnaire before and after the intervention. The participants were randomly assigned to take two capsules per day (totally 90 capsules for 6 weeks) of placebo or evening primrose (500 mg) for continuous 6 weeks. Then, the improvement in hot flashes was compared between two groups.

Results

The percent of improvement in hot flash frequency, severity and duration were 39, 42 and 19 %, in evening primrose group compared with 32, 32 and 18 % in placebo group, respectively. Although all three characters of hot flash was ameliorated in evening primrose arm, only its severity was significantly better in this arm compared with placebo group (P < 0.05). All HFRDIS score were significantly improved in two groups, but the percentage of improvement in social activities, relations with others, and sexuality was significantly superior to placebo group (P < 0.05).

Conclusions

The application of oral evening primrose oil compared with placebo for controlling hot flashes may decrease more the intensity of attacks as well as ameliorating the HFRDIS score.
Literatur
1.
Zurück zum Zitat Gold EB, Block G, Crawford S, Lachance L, FitzGerald G, Miracle H, Sherman S (2004) Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the study of women’s health across the nation. Am J Epidemiol 159(12):1189–1199. doi:10.1093/aje/kwh168 PubMedCrossRef Gold EB, Block G, Crawford S, Lachance L, FitzGerald G, Miracle H, Sherman S (2004) Lifestyle and demographic factors in relation to vasomotor symptoms: baseline results from the study of women’s health across the nation. Am J Epidemiol 159(12):1189–1199. doi:10.​1093/​aje/​kwh168 PubMedCrossRef
2.
Zurück zum Zitat Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. JAMA 288(3):321–333PubMedCrossRef Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J (2002) Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the women’s health initiative randomized controlled trial. JAMA 288(3):321–333PubMedCrossRef
6.
Zurück zum Zitat Vestergaard P, Hermann AP, Stilgren L, Tofteng CL, Sorensen OH, Eiken P, Nielsen SP, Mosekilde L (2003) Effects of 5 years of hormonal replacement therapy on menopausal symptoms and blood pressure––a randomised controlled study. Maturitas 46(2):123–132 pii: S0378512203001816PubMedCrossRef Vestergaard P, Hermann AP, Stilgren L, Tofteng CL, Sorensen OH, Eiken P, Nielsen SP, Mosekilde L (2003) Effects of 5 years of hormonal replacement therapy on menopausal symptoms and blood pressure––a randomised controlled study. Maturitas 46(2):123–132 pii: S0378512203001816PubMedCrossRef
7.
Zurück zum Zitat Panidis D, Rousso D, Kourtis A, Giannoulis C, Mavromatidis G, Stergiopoulos K (2001) Hormone replacement therapy at the threshold of 21st century. Eur J Obstet Gynecol Reprod Biol 99(2):154–164 [pii: S0301211501004055]PubMedCrossRef Panidis D, Rousso D, Kourtis A, Giannoulis C, Mavromatidis G, Stergiopoulos K (2001) Hormone replacement therapy at the threshold of 21st century. Eur J Obstet Gynecol Reprod Biol 99(2):154–164 [pii: S0301211501004055]PubMedCrossRef
8.
Zurück zum Zitat Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R, Dailey M, Freeman R, Hays J (2004) Conjugated equine estrogens and global cognitive function in postmenopausal women: women’s health initiative memory study. JAMA 291(24):2959–2968. doi:10.1001/jama.291.24.2959 PubMedCrossRef Espeland MA, Rapp SR, Shumaker SA, Brunner R, Manson JE, Sherwin BB, Hsia J, Margolis KL, Hogan PE, Wallace R, Dailey M, Freeman R, Hays J (2004) Conjugated equine estrogens and global cognitive function in postmenopausal women: women’s health initiative memory study. JAMA 291(24):2959–2968. doi:10.​1001/​jama.​291.​24.​2959 PubMedCrossRef
9.
Zurück zum Zitat Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin replacement study (HERS) research group. JAMA 280(7):605–613PubMedCrossRef Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E (1998) Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin replacement study (HERS) research group. JAMA 280(7):605–613PubMedCrossRef
10.
Zurück zum Zitat Beral V (2003) Breast cancer and hormone––replacement therapy in the million women study. Lancet 362(9382):419–427 [pii: S0140673603140652]PubMedCrossRef Beral V (2003) Breast cancer and hormone––replacement therapy in the million women study. Lancet 362(9382):419–427 [pii: S0140673603140652]PubMedCrossRef
11.
Zurück zum Zitat National Institutes of Health (2005) National institutes of health state-of-the-science conference statement: management of menopause-related symptoms Ann Intern Med 142(12 Pt 1):1003–1013 [pii: 0000605-200506210-00117] National Institutes of Health (2005) National institutes of health state-of-the-science conference statement: management of menopause-related symptoms Ann Intern Med 142(12 Pt 1):1003–1013 [pii: 0000605-200506210-00117]
13.
Zurück zum Zitat Carroll DG (2006) Nonhormonal therapies for hot flashes in menopause. Am Fam Physician 73(3):457–464PubMed Carroll DG (2006) Nonhormonal therapies for hot flashes in menopause. Am Fam Physician 73(3):457–464PubMed
14.
Zurück zum Zitat Chenoy R, Hussain S, Tayob Y, O’Brien PM, Moss MY, Morse PF (1994) Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. BMJ 308(6927):501–503PubMedCrossRef Chenoy R, Hussain S, Tayob Y, O’Brien PM, Moss MY, Morse PF (1994) Effect of oral gamolenic acid from evening primrose oil on menopausal flushing. BMJ 308(6927):501–503PubMedCrossRef
15.
Zurück zum Zitat Bassey EJ, Littlewood JJ, Rothwell MC, Pye DW (2000) Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre and postmenopausal women: two randomized controlled trials of Efacal versus calcium alone. Br J Nutr 83(6):629–635 [pii: S0007114500000805]PubMedCrossRef Bassey EJ, Littlewood JJ, Rothwell MC, Pye DW (2000) Lack of effect of supplementation with essential fatty acids on bone mineral density in healthy pre and postmenopausal women: two randomized controlled trials of Efacal versus calcium alone. Br J Nutr 83(6):629–635 [pii: S0007114500000805]PubMedCrossRef
16.
Zurück zum Zitat Conquer JA, Roelfsema H, Zecevic J, Graham TE, Holub BJ (2002) Effect of exercise on FA profiles in n-3 FA-supplemented and nonsupplemented premenopausal women. Lipids 37(10):947–951PubMedCrossRef Conquer JA, Roelfsema H, Zecevic J, Graham TE, Holub BJ (2002) Effect of exercise on FA profiles in n-3 FA-supplemented and nonsupplemented premenopausal women. Lipids 37(10):947–951PubMedCrossRef
18.
Zurück zum Zitat Carpenter JS (2001) The hot flash related daily interference scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manage 22(6):979–989 [pii: S0885392401003530]PubMedCrossRef Carpenter JS (2001) The hot flash related daily interference scale: a tool for assessing the impact of hot flashes on quality of life following breast cancer. J Pain Symptom Manage 22(6):979–989 [pii: S0885392401003530]PubMedCrossRef
22.
Zurück zum Zitat Loprinzi CL, Sloan J, Stearns V, Slack R, Iyengar M, Diekmann B, Kimmick G, Lovato J, Gordon P, Pandya K, Guttuso T Jr, Barton D, Novotny P (2009) Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol 27(17):2831–2837. doi:10.1200/JCO.2008.19.6253 PubMedCrossRef Loprinzi CL, Sloan J, Stearns V, Slack R, Iyengar M, Diekmann B, Kimmick G, Lovato J, Gordon P, Pandya K, Guttuso T Jr, Barton D, Novotny P (2009) Newer antidepressants and gabapentin for hot flashes: an individual patient pooled analysis. J Clin Oncol 27(17):2831–2837. doi:10.​1200/​JCO.​2008.​19.​6253 PubMedCrossRef
23.
Zurück zum Zitat Loprinzi CL, Qin R, Balcueva EP, Flynn KA, Rowland KM Jr, Graham DL, Erwin NK, Dakhil SR, Jurgens DJ, Burger KN (2010) Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1. J Clin Oncol 28(4):641–647. doi:10.1200/JCO.2009.24.5647 PubMedCrossRef Loprinzi CL, Qin R, Balcueva EP, Flynn KA, Rowland KM Jr, Graham DL, Erwin NK, Dakhil SR, Jurgens DJ, Burger KN (2010) Phase III, randomized, double-blind, placebo-controlled evaluation of pregabalin for alleviating hot flashes, N07C1. J Clin Oncol 28(4):641–647. doi:10.​1200/​JCO.​2009.​24.​5647 PubMedCrossRef
24.
Zurück zum Zitat Aidelsburger P, Schauer S, Grabein K, Wasem J (2012) Alternative methods for the treatment of post-menopausal troubles. GMS Health Technol Assess 8: Doc03. doi:10.3205/hta000101 Aidelsburger P, Schauer S, Grabein K, Wasem J (2012) Alternative methods for the treatment of post-menopausal troubles. GMS Health Technol Assess 8: Doc03. doi:10.​3205/​hta000101
25.
Zurück zum Zitat Bordeleau L, Pritchard KI, Loprinzi CL, Ennis M, Jugovic O, Warr D, Haq R, Goodwin PJ (2010) Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. J Clin Oncol 28(35):5147–5152. doi:10.1200/JCO.2010.29.9230 PubMedCrossRef Bordeleau L, Pritchard KI, Loprinzi CL, Ennis M, Jugovic O, Warr D, Haq R, Goodwin PJ (2010) Multicenter, randomized, cross-over clinical trial of venlafaxine versus gabapentin for the management of hot flashes in breast cancer survivors. J Clin Oncol 28(35):5147–5152. doi:10.​1200/​JCO.​2010.​29.​9230 PubMedCrossRef
26.
Zurück zum Zitat Maclennan AH, Broadbent JL, Lester S, Moore V (2004) Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev (4): CD002978 doi:10.1002/14651858.CD002978.pub2 Maclennan AH, Broadbent JL, Lester S, Moore V (2004) Oral oestrogen and combined oestrogen/progestogen therapy versus placebo for hot flushes. Cochrane Database Syst Rev (4): CD002978 doi:10.​1002/​14651858.​CD002978.​pub2
27.
Zurück zum Zitat Stein DJ, Baldwin DS, Dolberg OT, Despiegel N, Bandelow B (2006) Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram. J Clin Psychiatry 67(11):1741–1746PubMedCrossRef Stein DJ, Baldwin DS, Dolberg OT, Despiegel N, Bandelow B (2006) Which factors predict placebo response in anxiety disorders and major depression? An analysis of placebo-controlled studies of escitalopram. J Clin Psychiatry 67(11):1741–1746PubMedCrossRef
28.
Zurück zum Zitat Papakostas YG, Daras MD (2001) Placebos, placebo effect, and the response to the healing situation: the evolution of a concept. Epilepsia 42(12):1614–1625PubMedCrossRef Papakostas YG, Daras MD (2001) Placebos, placebo effect, and the response to the healing situation: the evolution of a concept. Epilepsia 42(12):1614–1625PubMedCrossRef
Metadaten
Titel
The effect of oral evening primrose oil on menopausal hot flashes: a randomized clinical trial
verfasst von
Farah Farzaneh
Setareh Fatehi
Mohammad-Reza Sohrabi
Kamyab Alizadeh
Publikationsdatum
01.11.2013
Verlag
Springer Berlin Heidelberg
Erschienen in
Archives of Gynecology and Obstetrics / Ausgabe 5/2013
Print ISSN: 0932-0067
Elektronische ISSN: 1432-0711
DOI
https://doi.org/10.1007/s00404-013-2852-6

Weitere Artikel der Ausgabe 5/2013

Archives of Gynecology and Obstetrics 5/2013 Zur Ausgabe

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.